Even though it was not among the highlighted portions, STXBP1 was validated as a key finding, as it is implicated in both brain tumors and epilepsy [17,25,26], being therefore not only a known biomarker of brain disease but also a potential target for therapy [17]. Here, STXBP1 is linked to epilepsy.